Interleukin-23: A central cytokine in the pathogenesis of spondylarthritis
Open Access
- 30 August 2011
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 63 (12) , 3668-3671
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Ankylosing spondylitis macrophage production of higher levels of interleukin-23 in response to lipopolysaccharide without induction of a significant unfolded protein responseArthritis & Rheumatism, 2011
- Analysis of IL-17+cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune responseArthritis Research & Therapy, 2011
- Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responsesProceedings of the National Academy of Sciences, 2011
- Th17 Cells Expressing KIR3DL2+ and Responsive to HLA-B27 Homodimers Are Increased in Ankylosing SpondylitisThe Journal of Immunology, 2011
- Generation of pathogenic TH17 cells in the absence of TGF-β signallingNature, 2010
- Endoplasmic reticulum stress-induced transcription factor, CHOP, is crucial for dendritic cell IL-23 expressionProceedings of the National Academy of Sciences, 2010
- Endogenous PGE2 promotes the induction of human Th17 responses by fungal β-glucanJournal of Leukocyte Biology, 2010
- Genetics of ankylosing spondylitisCurrent Opinion in Rheumatology, 2010
- From HLA‐B27 to spondyloarthritis: a journey through the ERImmunological Reviews, 2009
- Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritisArthritis & Rheumatism, 2009